Skip to search formSkip to main contentSkip to account menu

Erythromycin 333 MG Delayed Release Oral Tablet [PCE]

Known as: ERYTHROMYCIN ETHYLSUCCINATE 333 mg ORAL TABLET [PCE], PCE 333 MG Delayed Release Oral Tablet 
National Institutes of Health

Related topics

Related topics

14 relations
Delayed Release Oral TabletErythromycinErythromycin EthylsuccinateLactose

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
California Center for Population Research On-line Working Paper Series Sometimes It Takes a Village: Collective Efficacy and Children's Use of Preventive Health Care
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)